CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-16 | Morris Ronnie CEO | Option exercise · Warrant to purchase shares of Common Stock | −4,167 | 126,940 | ||
| 2019-01-08 | Battery Ventures IX, L.P. 10% owner | Option exercise | +58,333 | $4.80 | $280K | 2,011,882 |
| 2019-01-02 | ACKERMAN JOEL Director | Option exercise | +4,167 | $4.80 | $20K | 1,113,877 |
| 2019-01-02 | ACKERMAN JOEL Director | Option exercise · Warrant to purchase shares of Common Stock | +4,167 | 1,494,956 | ||
| 2018-12-19 | Morris Ronnie CEO | Purchase | +20,000 | $7.44 | $149K | 833,001 |
| 2018-11-06 | Mendelson Daniel Newman Director | Sale | −5,000 | $13.75 | $69K | 57,500 |
| 2018-11-01 | Poliakoff Abba David Director | Grant or award · Option to purchase Common Stock | +10,000 | $12.73 | $127K | 10,000 |
| 2018-11-01 | Breitfeld Philip P. Director | Grant or award · Option to purchase Common Stock | +8,333 | $12.73 | $106K | 8,333 |
| 2018-11-01 | TOBIN SCOTT R Director | Grant or award · Option to purchase Common Stock | +10,000 | $12.73 | $127K | 10,000 |
| 2018-11-01 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +16,667 | $12.73 | $212K | 16,667 |
| 2018-11-01 | Mendelson Daniel Newman Director | Grant or award · Option to purchase Common Stock | +10,000 | $12.73 | $127K | 10,000 |
| 2018-11-01 | SIDRANSKY DAVID Director | Grant or award · Option to purchase Common Stock | +8,333 | $12.73 | $106K | 8,333 |
| 2018-10-12 | ACKERMAN JOEL Director | Option exercise | +100,000 | $2.10 | $210K | 1,121,731 |
| 2018-10-12 | ACKERMAN JOEL Director | Shares withheld for taxes | −12,021 | $17.47 | $210K | 1,109,710 |
| 2018-10-12 | ACKERMAN JOEL Director | Option exercise · Option to purchase Common Stock | −100,000 | 0 | ||
| 2018-10-11 | Morris Ronnie CEO | Gift | −303,581 | $12.34 | $3.7M | 813,001 |
| 2018-10-01 | ACKERMAN JOEL Director | Sale | −22,535 | $17.02 | $384K | 1,021,731 |
| 2018-09-20 | Mendelson Daniel Newman Director | Sale | −8,333 | $13.02 | $108K | 62,500 |
| 2018-03-27 | Morris Ronnie CEO | Purchase | +2,300 | $3.62 | $8K | 1,116,582 |
| 2018-03-26 | Morris Ronnie CEO | Purchase | +2,235 | $3.57 | $8K | 1,114,282 |
Page 9 of 20 · 398 trades